Company: HROW
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001641172-25-022980
Chunk: 50

Company: HARROW, INC.
Filing Date: 2025-08-11
Form: 10-Q
Item: Item 1
Chunk 50
---
,  
    June 30, 

    2025  
    2024  
    2025  
    2024 
  
    IHEEZO 
    $18,336,000  
    $11,295,000  
    $23,558,000  
    $13,616,000 
  
    VEVYE 
     18,641,000  
     4,315,000  
     40,156,000  
     6,912,000 
  
    Other branded products 
     5,212,000  
     11,681,000  
     6,169,000  
     20,553,000 
  
    Other revenues 
     85,000  
     68,000  
     171,000  
     147,000 
  
    Branded revenue, net 
     42,274,000  
     27,359,000  
     70,054,000  
     41,228,000 
  
    ImprimisRx revenue, net 
     21,468,000  
     21,580,000  
     41,519,000  
     42,298,000 

    Total revenues, net 
    $63,742,000  
    $48,939,000  
    $111,573,000  
    $83,526,000 

Other
than IHEEZO and VEVYE, no other products accounted for more than 10% of total revenues for the periods presented.

Customer
and Supplier Concentrations

Substantially
all of the Company’s Branded sales are made to third-party distributors who sell the products to pharmacies and to the end-users.
There were two customers who comprised more than 10% of the Company’s Branded revenues for the three and six months ended June
30, 2025 and one customer who comprised more than 10% of the Company’s Branded revenues for the three and six months ended June
30, 2024. There were no customers who comprised more than 10% of ImprimisRx revenues for the three and six months ended June 30, 2025
and 2024. As of June 30, 2025 and December 31, 2024, accounts receivable from two